Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) EPS (Basic) (2016 - 2025)

Orthofix Medical (OFIX) has disclosed EPS (Basic) for 16 consecutive years, with -$0.05 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) rose 93.33% year-over-year to -$0.05, compared with a TTM value of -$2.33 through Dec 2025, up 29.18%, and an annual FY2025 reading of -$2.33, up 29.39% over the prior year.
  • EPS (Basic) was -$0.05 for Q4 2025 at Orthofix Medical, up from -$0.57 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.13 in Q2 2021 and bottomed at -$1.71 in Q1 2023.
  • Average EPS (Basic) over 5 years is -$0.62, with a median of -$0.58 recorded in 2025.
  • The sharpest move saw EPS (Basic) soared 113.68% in 2021, then tumbled 991.67% in 2023.
  • Year by year, EPS (Basic) stood at -$1.67 in 2021, then skyrocketed by 79.04% to -$0.35 in 2022, then plummeted by 68.57% to -$0.59 in 2023, then decreased by 27.12% to -$0.75 in 2024, then surged by 93.33% to -$0.05 in 2025.
  • Business Quant data shows EPS (Basic) for OFIX at -$0.05 in Q4 2025, -$0.57 in Q3 2025, and -$0.36 in Q2 2025.